Cholesterol Testing - Research and Markets - RSS Feed

Cholesterol and Other Cardiovascular Testing - Trends & Opportunities Worldwide

press@researchandmarkets.com — Tue, 17 Nov 2009 10:36:16 GMT

Cholesterol testing is fast gaining ground as the basic and most important marker for assessing the risk of heart disease, the number one killer. Various studies have proven the link between increased risk of cardiovascular disease (CVD) and abnormally high levels of cholesterol or lipid disorders. Rising levels of awareness and growing health consciousness among adults and at-risk patient population is contributing to increased frequency of cholesterol testing. A noticeable trend is the emergence of home cholesterol test kits, which are available as over the counter products.

Technological innovations are making these kits more reliable, fast, easy to use, and cost effective, compared to laboratory testing, thus explaining the significant growth for this category. On the other hand, several new variants of cardiovascular and other tests, such as homocysteine tests are seeing the light of the day, promising more clarity in CVD risk assessment. All this translates into burgeoning potential for makers of cholesterol testing devices, clinics offering testing services.

These and other market data and trends are presented in "Cholesterol & Other Cardiovascular Testing: Trends & Opportunities Worldwide" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

Heart Health Food and Drinks: NPD in Cardiovascular Health, Hypertension and Cholesterol Reduction

press@researchandmarkets.com — Wed, 02 Apr 2008 15:37:52 GMT

Business Insights' portfolio of consumer goods management reports are designed to help you make well informed and timely business decisions We understand the problems facing today's consumer goods executives when trying to drive your business forward, and appreciate the importance of accurate,...

Cholesterol & Other Cardiovascular Testing - Global Strategic Business Report

press@researchandmarkets.com — Tue, 06 Jun 2006 12:10:54 GMT

This report analyzes the worldwide markets for Cholesterol & Other Cardiovascular Testing in Millions of Units. The specific product segments analyzed are Lipid Panel Test/Complete Lipid Profile, Total Cholesterol Test, HDL Cholesterol Test, Apolipoprotein B, and Other Apolipoprotein Tests. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 48 companies including many key and niche players worldwide such as AccuTech, LLC, Axis-Shield PLC, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd., Home Access Health Corporation, Inverness Medical Innovations, Inc., Biosite Inc., Cholestech Corporation, Polymer Technology Systems, Inc., and Siemens Healthcare Diagnostics, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks.

For information on site licence pricing please click on Enquire before buying

Cholesterol Testing And Cholesterol Reduction Product: Usage By Americans Aged 50 And Over

press@researchandmarkets.com — Fri, 20 Aug 2004 12:01:24 GMT

This report gives extensive data on how often Americans test their cholesterol, their cholesterol level, usage of specific cholesterol control drugs, supplements and herbs, and views on the need to control cholesterol More than 40 tables of data Excerpts from this study: Nearly 40% of the...

Landmark Anti-dyslipidemic Trials Update - How Low Can You Go?

press@researchandmarkets.com — Tue, 13 Jul 2004 11:38:45 GMT

Introduction
The Heart Protection Study showed that patients with normal LDL cholesterol, as defined by the NCEP guidelines, experienced equal benefit from LDL cholesterol reduction as those with high LDL cholesterol. These results have been confirmed by the REVERSAL, PROVE-IT and ALLIANCE trials,